Concepedia

Ke Wei

KW

Statistics

Publications

43

Citations

2.2K

H-Index

29

Active since

2001

Affiliations

Nanjing Medical University(Current)

Jiangsu Province Hospital

Stanford University

Stanford Medicine

University of California, Los Angeles

Ke Wei is an author at Nanjing Medical University specializing in oncology, medicine, and life sciences.

ORCID

Publications per year

2001–2025

43

Publications

43

Triptolide and Chemotherapy Cooperate in Tumor Cell Apoptosis

Wenteh Chang, Jason Kang, Kye-Young Lee et al. · Journal of Biological Chemistry · 2001 · 163 citations · Full text

, , +17

M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942

Ke Wei, Zijian Ma, Fengming Yang et al. · Cancer Letters · 2021 · 144 citations

, , +14

PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy.

John M. Fidler, Ke Li, Cathie T. Chung et al. · PubMed · 2003 · 117 citations

, , +15

SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of β-Catenin

Wenteh Chang, Ke Wei, Susan S. Jacobs et al. · Journal of Biological Chemistry · 2010 · 111 citations · Full text

, , +17

Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer

Zijian Ma, Ke Wei, Fengming Yang et al. · Cell Death and Disease · 2021 · 104 citations · Full text

, , +17

1–5 of 43